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Abstract
Background: This study aimed to determine whether intra-articularly injected adipose-derived stem cells (ADSCs)
inhibited articular cartilage degeneration during osteoarthritis (OA) development in a rabbit anterior cruciate
ligament transection (ACLT) model. The paracrine effects of ADSCs on chondrocytes were investigated using a
co-culture system.
Methods: ACLT was performed on both knee joints of 12 rabbits. ADSCs were isolated from the subcutaneous
adipose tissue. ADSCs with hyaluronic acid were intra-articularly injected into the left knee, and hyaluronic acid was
injected into the right knee. The knees were compared macroscopically, histologically, and immunohistochemically
at 8 and 12 weeks. In addition, cell viability was determined using co-culture system of ADSCs and chondrocytes.
Results: Macroscopically, osteoarthritis progression was milder in the ADSC-treated knees than in the control knees
8 weeks after ACLT. Histologically, control knees showed obvious erosions in both the medial and lateral condyles
at 8 weeks, while cartilage was predominantly retained in the ADSC-treated knees. At 12 weeks, the ADSC-treated
knees showed a slight suppression of cartilage degeneration, unlike the control knees.
Immunohistochemically, MMP-13 expression was less in the ADSC-treated cartilage than in the control knees. The
cell viability of chondrocytes co-cultured with ADSCs was higher than that of chondrocytes cultured alone.
TNF-alpha-induced apoptotic stimulation was similar between the two groups.
Conclusions: Intra-articularly injected ADSCs inhibited cartilage degeneration progression by homing to the
synovium and secreting a liquid factor having chondro-protective effects such as chondrocyte proliferation and
cartilage matrix protection.
Background
Osteoarthritis (OA) is characterized by the destruction
of the extracellular matrix and the loss of chondrocyte
function [1, 2]. Although OA affects a large proportion
of the population there are few, if any, effective therapies
available today that alter the pathobiologic course of the
disease [3]. For many years, scientists have been search-
ing for ways to inhibit the process of the disease and
slow the progression of joint damage [4]. This is the
driving force behind numerous ongoing efforts to de-
velop new tissue engineering-based strategies for the
treatment of OA [5, 6].
Mesenchymal stem cells (MSCs), with the capacity to
differentiate into a variety of cells including osteoblast,
tendon, muscle, adipose tissue, and chondrocyte [7, 8],
are used in cellular therapy for a broad spectrum of
diseases [9]. In a degenerative disease such as OA, the
stem cells are exhausted and their capability for prolifer-
ation and differentiation decreases [10]. Systemic or
local stem cell treatment can promote repair of the
articular cartilage [8], but studies have increasingly dem-
onstrated the low survival rate of the transplanted stem
cells [11], so recent research has focused on treatments
involving the paracrine effect of stem cells. Although
stem cells are primarily thought to act through tissue
differentiation, they can also act in a paracrine manner
via the production of soluble anti-inflammatory factors
[8, 12, 13].
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In this study, we investigated the clinical application
of one type of stem cells, adiposed-derived stem cells
(ADSCs), in various fields such as bones, peripheral
nerves, menisci, and ligaments [14–16]. ADSCs are
safe; they can easily be isolated from subcutaneous
adipose tissue and cultured in large quantities, making
them a good source of tissue stem cells. Some reports
have described the efficacy of an intra-articular injec-
tion of ADSCs in animal OA models. [3, 8, 12, 17, 18].
However, the role of ADSCs in the treatment of osteo-
arthritis is not clear [7, 9, 12, 19].
The primary purpose of this study was to determine
whether intra-articularly injected ADSCs prevented or
slowed articular cartilage degeneration during osteo-
arthritis (OA) development in a rabbit anterior cruciate
ligament transection (ACLT) model; in particular we
focused on the paracrine effect of ADSCs. Secondarily,
the mechanism underlying the paracrine effects of
ADSCs on chondrocytes was investigated in vitro.
Methods
The experimental protocol, using an animal model, was
approved by the Institute for Experimental Animals,
Kanazawa University Advanced Science Research Cen-
ter. Surgery was performed in accordance with the Guide
for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH publication
no.85-23, revised 1996), and using aseptic techniques.
Animals
Skeletally mature female Japanese white rabbits, weighing
between 2.5 and 3.0 kg, were used for this experiment.
Adipose-derived stem cells
ADSCs were isolated by modifying a previously reported
method [14, 20]. Adipose tissue (1.5 g) was harvested
from the posterior cervical subcutaneous adipose tissue
of a rabbit and washed with phosphate-buffered saline
(PBS) (Wako, Osaka, Japan). The tissue was cut into
strips over a period of 5 min. Collagenese (Wako) was
dissolved in PBS so that its concentration would be
0.12 % in 25 ml, and was used to digest adipose tissue at
37 °C for 45 min in a water bath. The mixture was
shaken every 15 min during the digestion period. Imme-
diately after the reaction was completed, 25 ml of
Dulbecco’s modified Eagle’s medium, DMEM (Wako),
was added to neutralize collagenase activity. The
resulting solution was filtered. The filtrate was centri-
fuged at 1300 rpm for 6 min at 25 °C, and the super-
natant was removed. Next, a pallet of ADSCs was
seeded at 5 × 104 cells/cm2 in 60.1-cm2 tissue culture
dishes and cultured with complete medium, DMEM
containing 10 % fetal bovine serum (FBS), 100 units/
ml penicillin, and 100 μg/ml streptomycin. After being
cultured for 1 week, the cells were harvested with
0.25 % trypsin-EDTA, centrifuged at 1300 rpm for
6 min, and washed twice with PBS. The obtained cells
were used for intra-articular injections in vivo and co-
culture assays in vitro.
In vivo experiments
Induction of experimental OA
Twelve rabbits were used for the in vivo experiments.
All were anesthetized by intramuscular injection of keta-
mine hydrochloride (35 mg/kg body weight; Sankyo
Pharmaceutical, Tokyo, Japan) and xylazine (5 mg/kg
body weight; Bayer, Tokyo, Japan), and intravenous
injection of pentobarbital sodium (40–50 mg/kg body
weight; Abbott Laboratories, Chicago, IL, USA).
Traumatic degeneration was induced as previously de-
scribed for the anterior cruciate ligament model [21, 22].
This model is characterized by OA-like damage. Hayashi
et al. noted that rabbits show considerable individual
variability in osteoarthritis progression at 4 weeks after
ACLT [23]. As they suggested, we used matched-pair
analysis to examine the paracrine effect of ADSCs on
osteoarthritis progression in a stricter manner.
Both knees were shaved and disinfected with iodine.
ACLT was performed as described by Yoshioka et al.
[22]. Briefly, a medial parapatellar incision was made
and an arthrotomy was performed. The patella was
dislocated laterally and the knee placed in full flexion.
The ACL was visualized and transected with a No.11
blade. An anterior drawing test was performed gently to
confirm that the ACL was transected completely. The
joint was irrigated with sterile saline and closed. A same
operation was performed in the contralateral knee. The
knee was opened and the patella was dislocated. After
gently performing the anterior drawing test, the joint
was irrigated and closed. After the operation, free activ-
ity was allowed in the cage without immobilization.
Injection of ADSCs
ADSCs were isolated from the subcutaneous adipose
tissue 3 weeks after ACLT and cultured for 1 week as
described above.
For matched –pair analysis of ADSCs, 12 rabbits (24
knees) were used. At 4, 5, 6 weeks after ACLT, ADSCs
(2.0 × 106 cells) in 100 μl PBS and 0.1 mL hyaluronic
acid (Synvisc®; kindly provided by Teijin Limited, Japan)
were intra-articularly injected into the left knee, using a
23 gauge needle. In right knees, the same volume of
plain PBS and and hyaluronic acid were injected as a
control. Immediately after injection, the rabbit was kept
down for 5 min so that injected ADSCs could be
attached around the synovium.
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Femoral condyles from both knees were harvested at 8
and 12 weeks after surgery following the intravenous
injection of 6 ml sodium pentobarbital.
Macroscopic analysis
The femoral condyles were dissected and stained with
India ink (American MasterTech, CA, USA). Macro-
scopic pictures were taken using a Panasonic LUMIX
digital camera (Panasonic, Tokyo, Japan). Gross findings
were classified and scored as described in our previous
reports [4, 23, 24]. The medial and lateral femoral con-
dyles were individually scored from grades 0 to 5 and
the two scores were summed to obtain a cumulative
macroscopic osteoarthritis score. A blind assessment
was then independently conducted by two individual
examiners (KK, TK) and the scores from the two exam-
iners were averaged to obtain an overall score.
Histological analysis
The dissected distal femurs were fixed in a 4 % parafor-
maldehyde solution after gross morphological examin-
ation. The specimens were decalcified in 4 % EDTA
solution, dehydrated with a gradient ethanol series, and
embedded in paraffin blocks.
Ten coronal sections were prepared in the coronal
plane through the middle of the femoral condyles, and
one section from each sample, which included the
most severely degenerated area, was used for each of
the histological analyses.
The specimens were stained with safranin O or H&E
using standard procedures.
Histological sections were visualized using a fluorescence
microscope (Keyence Japan, Osaka, Japan), assessed in a
blind manner by two individual examiners (TK, KK), and
quantified according to the cartilage OA histopathology
grading system methodology of the Osteoarthritis Research
Society International (OARSI) [25].
Immunohistochemical analysis
Immunohistochemical examinations were performed as
follows. In brief, after deparaffinization, sections were
incubated with 0.3 % hydrogen peroxide for 30 min.
Then, sections were treated with hyaluronidase for
60 min after which they incubated with mouse anti-
human MMP-13 monoclonal antibody (1:20; AnaSpec
Inc., San Jose, Ca, USA), or mouse anti-rabbit MMP-3
monoclonal antibody (1:50; Daiichi Fine Chemical Co.
Toyama, Japan) [26]. All antibody dilutions were made
in PBS. After an overnight reaction with the primary
antibody at 4 °C, sections were incubated with labeled
polymer-HRP anti-mouse IgG (Dako, Tokyo, Japan) at
room temperature for 30 min. Signals were visualized
with 3, 3’-diaminobenzidine tetrahydrochloride, and nuclei
were counterstained with hematoxylin. A semi-quantitative
method that assigns immunohistochemistry values as a per-
centage of positive cells (MMP-13, MMP-13) was provided
for a complete assessment of protein expression, with a
maximum score of 100 % [12].
Results of the histological and immunohistochemical
analyses were subjected to a blind evaluation by two ob-
servers (TK, KK).
DiI labeling
On the day of intra-articular injection, ADSCs were
labeled for cell tracking with a fluorescent lipophilic
tracer 1,10-dioctadecyl-3,3,30,30-tetramethylindocarbo-
cyanine perchlorate (DiI; MolecularProbes ). For label-
ing, the cells were re-suspended at 1 × 106 cells/ml in
aMEM, and DiI was added at 5 ml/ml in a serum-free
DMEM. After incubation for 20 min at 37 °C with 5 % hu-
midified CO2, the cells were centrifuged at 1300 rpm for
6 min and washed twice with PBS, then re-suspended in
PBS for the injection.
An examination was performed to determine where
the ADSCs existed after the intra-articular injection.
A fresh frozen coronal section containing a central




Primary culture of chondrocytes was performed using
articular cartilage tissues harvested from a rabbit. Briefly,
thinly sliced cartilage tissues were incubated with 0.15
trypsin with 0.1 % collagenase for one hour. Subse-
quently, cartilage tissues were incubated in DMEM with
0.15 % collagenase for 2 h 30 min. The cells were then
collected by centrifugation, seeded into collagen I coated
24-well plates (collagenI multiwell plates, BD Falcon™),
and cultured with DMEM containing 10 % FBS supple-
mented with 100 units/ml penicillin and 100 mg/ml
streptomycin at 37 °C in a humidified atmosphere of 5 %
CO2/95 % air. Chondrocytes were grown in monolayer
cultures, and were passaged when reaching confluence.
Cells at the second passage were used for the assay.
Co-culture assay
To confirm the paracrine effect of ADSCs for chondro-
cyte, we used the co-culture system (Fig. 1).
The co-culture groups were established between
ADSCs (5 × 103cells/well) in Cell culture inserts (Cell
Culture inserts, 0.4 μm pores, BD Falcon™) and chondro-
cytes (5 × 103cells/well) in twelve-well plates (Cell Cul-
ture Insert Companion Plates, BD Falcon™) in DMEM.
The control group was established between no cells in
Cell culture inserts and chondrocytes only in twelve-well
plates (5 × 103cells/well) in DMEM.
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After 48 h, cell viability of the chondrocyte group was
determined using the MTT assay and compared to that
of the co-culture group.
Subsequently, to confirm the paracrine effect of ADSCs
for chondrocyte under TNF-α, the culture experiments
were divided into 3 groups: chondrocytes (control); chon-
drocytes with TNF-α (10 ng/mL) (TNF-α); and co-culture
of ADSCs and chondrocytes with TNF-α (10 ng/mL)
(ADSCs). After 48 h, cell viability of the chondrocytes was
determined using the MTT assay and compared among
the three groups.
Next, 72 h after TNF-α stimulation, the concentration
of MMP-13 in the three groups was measured by
ELIZA. The Human Biotrak MMP-13 ELIZA kit (GE
Healthcare) was used because these kits were previously
shown to be suitable for assaying rabbit MMPs [28, 29].
We believe that quantifying the cellular survival rate
enabled us to evaluate the chondrocyte proliferative
effects of the paracrine effect of ADSCs, while the
MMP-13 quantification allowed us to evaluate the
chondrocyte matrix protection effects. TNF-α stimula-
tion induced chondrocyte apoptosis and reproduced
the clinical condition of OA.
Statistical analysis
Statistical analyses were performed using SPSS ver.19.0
(SPSS, Inc, Chicago, Ill). The results are shown as the
mean ± standard deviation (SD). The unpaired t-test was




At 8 weeks after ACLT, severe erosion in both medial
and lateral femoral condyles was observed in the control
group; 75 % of the condyles were graded “erosion”. At
the same time, in the ADSC group, near normal cartilage
or fibrillation was observed; only 25 % of the condyles
were graded “erosion”. In addition, the areas of damaged
cartilage appeared to be smaller than those in the control
knees in each rabbit.
Figure 2a shows an example of a typical control and
ADSC-treated condyle, 8 weeks after ACLT, stained with
india ink. In the control knees, erosions in both the
medial and lateral condyles can be seen. On the other
hand, in the ADSC-treated knees, no erosion was ob-
served; there were no macroscopically identifiable cartil-
age lesions in the medial condyle, and little fibrillation in
the lateral condyle.
The mean macroscopic OA score (8 weeks) for the
control group was 8.2 ± 1.5 while the ADSC group had a
mean score of 4.7 ± 2.8 (Fig. 2b); the lower score for the
ADSC group indicates less damage to the cartilage
surface. This was a statistically significant difference
(P = 0.019).
At 12 weeks after ACLT, severe erosion was observed
in both groups. The mean macroscopic OA score for the
control group was 7.5 ± 2.3 while the ADSC group had a
mean score of 5.7 ± 2.3 (Fig. 2c). There was no statisti-
cally significant difference (P = 0.20).
Histological analysis
Histologically, 8 weeks after ACLT control knees showed
an obvious loss of cartilage in both the medial and
lateral condyles, while the cartilage matrix was predom-
inantly retained in the ADSC-treated knees.
Figure 3a shows a typical histological section from a
control group condyle and an ADST-treated condyle. The
control group sections showed more cartilage defects.
At 8 weeks after ACLT, the mean OARSI score for the
control group was 13.0 ± 8.9 while the ADSCs group had
a mean score of 25.6 ± 4.1 (Fig. 3c). This was a statisti-
cally significant difference (P = 0.016).
At 12 weeks after ACLT, greater loss of cartilage was ob-
served in both the control and ADSC groups (Fig. 3b). The
mean OARSI score for the control group was 20.0 ± 2.8
while the ADSC group had a mean score of 19.0 ± 7.1
(Fig. 3d). There was no statistically significant difference
between the two (P > 0.05).
Immunohistochemical analysis
MMP-3 and MMP-13 are major proteases degrading the
extracellular matrix. The expression of these enzymes
was analyzed by immunohistochemistry using samples
prepared 8 weeks after ACLT.
For MMP-3, there were no significant differences
between the number of positive cells in the ADSC and
control groups (data are not shown).
The proportion of MMP-13-positive cells, however,
was significantly lower in sections of the ADSC groups
than in sections of the control group (Fig. 4b).
Fig. 1 The co-culture system is comprised of ADSCs in Cell culture
inserts and chondrocytes in twelve-well plates. ADSCs in itself cannot
pass cell culture inserts, but but secreted factors from ADSCs can pass
cell inserts and affect chondrocytes
Kuroda et al. BMC Musculoskeletal Disorders  (2015) 16:236 Page 4 of 10
DiI labeling
DiI positive areas are shown in Fig. 5a and b. Figure 5a
reveals that intra-articular injected cells survived and
homed to the subintimal layers of the synovium and
ligament, but not the cartilage, 8 weeks after ACLT. On
the other hand, at 12 weeks after ACLT, no DiI positive
cells were observed (Fig. 5b).
in vitro
Co-culture assay
To confirm the paracrine effect of ADSCs on chondro-
cytes, their cell viability was evaluated using a co-culture
system (Fig. 5).
The cell viability of chondrocytes co-cultured with
ADSCs was higher than that of chondrocytes cultured
alone (Fig. 6a). Similar results were obtained under
TNF-α stimulation. The cell viability of chondrocytes
co-cultured with ADSCs was higher than that of those
cultured alone under TNF-α stimulation (Fig. 6b).
To confirm the paracrine effect of ADSCs on MMP-13
expression, the concentration of MMP-13 in the co-
culture and control groups was evaluated by ELIZA. At
72 h after TNF-α stimulation, the concentration of
MMP-13 in the medium of the co-culture group was
lower than that in the medium of the chondrocyte alone
group, as shown in Fig. 7. This indicates that the expres-
sion of MMP-13 was reduced by the paracrine effect of
the ADSCs.
Discussion
In this study, we found that intra-articularly injected
ADSCs inhibited cartilage degeneration progression in a
rabbit OA model, and homed to intra-articular soft
tissue (the subintimal layers of the synovium, ligament).
Furthermore, we focused on the paracrine effects of
ADSCs; intra-articularly injected ADSCs could secrete a
liquid factor having chondro-protective effects, such as
chondrocyte proliferation and cartilage matrix protection.
Adipose tissue is known to play a key role in energy
balance and metabolic disorders [9]. Moreover, a recent
study demonstrated that adipose tissue hosts multipo-
tent stem cells [30]. These cells, called adipose tissue-
derived stromal cells or adipose stem cells (ASCs), were
first reported in 2001 by Zuk et al. [20]. ADSCs have the
capacity to differentiate into a variety of cells, including
adipocytes, osteoblasts, chondrocytes, and myocytes
under specific culture conditions in vitro [31].
On the other hand, some reports note that when the
chondrogenic potential of MSCs derived from bone mar-
row and from adipose tissue were compared in vitro and
in vivo, chondrogenesis was superior in those derived
from bone marrow [32, 33].
ADSCs are used for chondro-protective therapy because
autologous ADSCs can easily be isolated in large amounts
from subcutaneous adipose tissue [14]. Also ADSCs can
be harvested less invasively than BMSCs, and many more
stem cells can be harvested at one time [34, 35]. In clinical
applications, autologous ADSCs should be used from the
Fig. 2 Macroscopic analyses of the femoral condyles. a Representative specimen 8 weeks after ACLT. To remove individual viability, both sides of
the knees of the same individuals are shown. The surface of the cartilage was stained with India ink to identify any fibrillation and erosion.
Laterality is shown as medial (M) and lateral (L). b Macroscopic osteoarthritis score 8 weeks after ACLT (n = 6). c Macroscopic osteoarthritis score
12 weeks after ACLT (n = 6)
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Fig. 3 Histological analyses of the femoral condyles. a Representative specimen 8 weeks after ACLT. b Representative specimen 12 weeks after
ACLT. Bothe sides of the knees from same individuals are shown. Distal femur was sectioned coronally and stained with safranin-O. Bars, 500 μm.
c The OARSI OA score 8 weeks after ACLT (n = 6). d The OARSI OA score 12 weeks after ACLT (n = 6)
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perspective of safety, and ADSCs should be minimally
manipulated. This is why ADSCs are emerging as an alter-
native to BMSCs in the orthopaedic field [17].
We also focused on the paracrine effect of ADSCs as a
new method for chondro-protective therapy.
It is generally believed that the primary therapeutic
effect of stem cells occurs through tissue differentiation
because stem cells can differentiate toward various types
of cells [36]. Lee et al. reported that injected MSCs were
present in neocartilage [37]. On the other hand, bioactive
factors secreted by stem cells can influence the local tissue
environment and exert a protective effect. [38, 39]. Arnold
Caplan first proposed MSCs as a trophic mediator for
tissue repair [38]. In addition, MSCs have a trophic, anti-
inflammatory and immunosuppressive action, by modulat-
ing T and B cells and inducing the expression of anti –in-
flammatory factors, such as interleukin 10 (IL-10), IL-1
receptor antagonist (IL-1 RA), or prostaglandin E2
(PGE2) [17].
In this study, intra-articularly injected DiI-ADSCs
homed to intra-articular soft tissue (the subintimal layers
of the synovium, ligament) 8 weeks after ACLT, but
there were few in articular cartilage. The above results
indicate that the paracrine effect of ADSCs which
homed in intra-articular soft tissue contributed largely
to the inhibition of cartilage degeneration progression,
not regeneration by ADSC differentiation.
There have been many reports concerning the
therapeutic properties of ADSCs for cartilage defects
[40, 41]. In recent years, several researchers have sug-
gested the effectiveness of ADSCs as treatment for
OA [7–9, 12, 17, 19, 42].
In our study, osteoarthritis progression was obviously
milder in the ADSC-treated knees than in the control
knees 8 weeks after ACLT in both macroscopic and
histological evaluation. This is the data supporting the
efficacy of ADSCs for OA treatment that other reports
also have suggested.
Despite the results showing the chondro-protective ef-
fects of ADSCs, it is important to mention that the mech-
anism by which ADSC therapy facilitates tissue repair is
still unclear. Toghraie et al. indicated that the injected
ADSCs may regenerate degenerative tissue after directly
filling the lesion [7], but there is insufficient evidence for
this. Other reports have suggested that that injected
ADSCs indirectly stimulate the secretion of bioactive fac-
tors such as cytokines and growth factors [9, 12, 42, 43].
We also focused on the paracrine effects of ADSCs, espe-
cially the effect on chondrocytes. We investigated these
paracrine effects using a co-culture system.
Fig. 4 Immunohistochemical analysis for MMP-13 in cartilage. a
Representive specimens 8 weeks after ACLT, evaluated for MMP-13
in medial femoral condyle. Medial sides of the knees from same
individuals are shown. MMP-13 positive cells are indicated by arrows.
Bars, 500 μm. b The proportion of MMP-13 positive cells (n = 6)
Fig. 5 DiI labeling at 8 weeks (a) and 12 weeks (b) after ACLT; After
intra-articular injection of ADSCs labeled with DiI dye, frozen sections
were prepared and then stained with hematoxylin and eosin. DiI
positive cells survived and homed to the subintimal layers of the
synovium (S) and ligament (L), not in the cartilage at 8 weeks
after ACLT
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Wu et al. investigated the paracrine effect of MSCs on
chondrocytes using a co-culture system [44]. Tsuchiya et al.
first reported that co-culture of BMSCs and articular chon-
drocytes enhanced matrix production [45]. Meanwhile,
Hildner et al. also reported increased cartilage formation in
the co-culture of chondrocytes with ADSCs [46].
Our data showed a significant increase of chondro-
cytes in co-culture with ADSCs. Furthermore, although
TNF-α led to the death of chondrocytes (Fig. 6b Control
VS TNF-α), the effect of TNF-α was suppressed when
chondrocytes were co-cultured with ADSCs (Fig. 6b
TNF-α VS ADSCs + TNF-α). These results indicate that
the paracrine effects of ADSCs have effects such as regu-
lating chondrocyte viability in osteoarthritis.
It is believed that MMP13 causes damage to cartilage
in OA, and that this is mediated by chondrocytes in an
autocrine or paracrine manner [47]. We showed that
production of MMP-13 in articular chondrocytes was
reduced when they are treated with injected ADSCs in
vivo, and the MMP-13 concentration of culture fluid
was also reduced when co-cultured with ADSCs in vitro.
These data suggest that ADSCs protect the articular
cartilage from degeneration by inhibiting MMP13 ex-
pression and secreting multiple growth factors.
In our results, intra-articularly injected ADSCs had an
inhibiting effect on cartilage degeneration progression
8 weeks after ACLT, but did not show a significant effect
at 12 weeks. Furthermore, no DiI positive cells were ob-
served 12 weeks after ACLT. This is why intra-
articularly injected ADSCs might not survive in a joint,
so the paracrine effect lasted only weeks.
Conclusions
Intra-articularly injected ADSCs inhibited cartilage
degeneration progression in a rabbit OA model by hom-
ing to the synovium and secreting a liquid factor with
chondro-protective effects such as regulating chondro-
cyte viability and cartilage matrix protection.
Abbreviations
ACLT: Anterior cruciate ligament transection; ADSCs: Adipose-derived stem cells;
DMEM: Dulbecco’s modified Eagle’s medium; FBS: Fetal bovine serum;
H&E: Hematoxylin & eosin; IL: Interleukin; MMP: Matrix metalloproteinase;
MSCs: Mesenchymal stem cells; OA: Osteoarthritis; PBS: Phosphate-buffered
saline; PG: Prostaglandin; SD: Standard deviation; TNF-α: Tumor necrosis factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KK conceived the study, conducted the experiments, analyzed the data and
wrote the first draft of the manuscript. TK conceived the study, analyzed the
data, and provided additional advice. KHay provided additional advice. TM,
YK, SI were involved in the design of the experiments. KF, KHas and DI
performed the anesthesia procedures and the administration of cells into the
rabbit knee joint. NS analyzed the data, provided additional advice. HT
conceived the study, provided additional advice. All authors were involved in
interpretation of the results. All authors commented on and accepted the
submitted manuscript. All authors read and approved the final manuscript.
Fig. 6 Cell viability of chondrocyte was determined using the MTT
assay and compared (a) between chondrocyte group and co-culture
group, (b) between each groups; chondrocytes (control), chondrocytes
with TNF-α (10 ng/mL) (TNF-α); and co-culture of ADSCs and
chondrocytes with TNF-α (10 ng/mL) (ADSCs + TNF-α)
Fig. 7 MMP-13 levels in medium of co-culture of ADSCs and
chondrocytes with TNF-α and chondrocyte cultured alone with
TNF-α. MMP-13 was measured by ELIZA
Kuroda et al. BMC Musculoskeletal Disorders  (2015) 16:236 Page 8 of 10
Acknowledgments
The authors thank Mr. Toshiya Nomura and Ms. Yoko Kasai for their skillful
technical assistance. No funding was received for this manuscript.
Author details
1Department of Orthopaedic Surgery, Graduate School of Medical Science,
Kanazawa University, 13-1, Takara-machi, Kanazawa 920-8641, Japan.
2Department of Physiology, Graduate School of Medical Science, Kanazawa
University, Kanazawa, Japan.
Received: 27 April 2015 Accepted: 28 August 2015
References
1. Mankin HJ, Lippiello L. Biochemical and metabolic abnormalities in articular
cartilage from osteo-arthritic human hips. J Bone Joint Surg Am.
1970;52:424–34.
2. Lee SW, Song YS, Lee SY, Yoon YG, Lee SH, Park BS, et al. Downregulation
of protein kinase CK2 activity facilitates tumor necrosis factor-α-mediated
chondrocyte death through apoptosis and autophagy. PLoS One.
2011;29:e19163.
3. Wakitani S, Goto T, Pineda SJ, Pineda SJ, Young RG, Mansour JM, et al.
Mesenchymal cell-based repair of large, full-thickness defects of articular
cartilage. J Bone Joint Surg Am. 1994;76:579–92.
4. Hayashi M, Muneta T, Ju YJ, Mochizuki T, Sekiya I. Weekly intra-articular
injections of bone morphogenetic protein-7 inhibits osteoarthritis
progression. Arthritis Res Ther. 2008;10:R118.
5. Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell
therapy for knee osteoarthritis. Knee. 2012;19:902–7.
6. Hardingham T, Tew S, Murdoch A. Tissue engineering: chondrocytes and
cartilage. Arthritis Res. 2002;4:S63–8.
7. Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S,
et al. Treatment of osteoarthritis with infrapatellar fat pad derived
mesenchymal stem cells in Rabbit. Knee. 2011;18:71–5.
8. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine
model of osteoarthritis. Arthritis Rheum. 2003;48:3464–74.
9. ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, et
al. Antiinflammatory and chondroprotective effects of intraarticular injection
of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum.
2012;64:3604–13.
10. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced
chondrogenic and adipogenic activity of mesenchymal stem cells from
patients with advanced osteoarthritis. Arthritis Rheum. 2002;46:704–13.
11. Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. Fate of culture-
expanded mesenchymal stem cells in the microvasculature : in vivo
observations of cell kinetics. Circ Res. 2009;13:398–402.
12. Desando G, Cavallo C, Sartoni F, Martini L, Parrilli A, Veronesi F, et al. Intra-
articular delivery of adipose derived stromal cells attenuates osteoarthritis
progression in an experimental rabbit model. Arthritis Res Ther. 2013;29:R22.
13. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem
cells recruit macrophages and endothelial lineage cells and enhance
wound healing. PLoS One. 2008;2:e1886.
14. Suganuma S, Tada K, Hayashi K, Takeuchi A, Sugimoto N, Ikeda K, et al.
Uncultured adipose-derived regenerative cells promote peripheral nerve
regeneration. J Orthop Sci. 2013;18:145–51.
15. Nomura I, Watanabe K, Matsubara H, Hayashi K, Sugimoto N, Tsuchiya H.
Uncultured Autogenous Adipose-derived Regenerative Cells Promote Bone
Formation During Distraction Osteogenesis in Rats. Clin Orthop Relat Res.
2014;472:3798–806.
16. Fang X, Murakami H, Demura S, Hayashi K, Matsubara H, Kato S, et al. A
novel method to apply osteogenic potential of adipose derived stem cells
in orthopaedic surgery. PLoS One. 2014;19:e88874.
17. Veronesi F, Maglio M, Tschon M, Aldini NN, Fini M. Adipose-derived
mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in
in vivo studies. J Biomed Mater Res A. 2014;102:2448–66.
18. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human
autologous culture expanded bone marrow mesenchymal cell
transplantation for repair of cartilage defects in osteoarthritic knees.
Osteoarthritis Cartilage. 2002;10:199–206.
19. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, et al.
Production of canine mesenchymal stem cells from adipose tissue and their
application in dogs with chronic osteoarthritis of the humeroradial joints.
Cell Biol Int. 2012;36:189–94.
20. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage
cells from human adipose tissue: implications for cell-based therapies.
Tissue Eng. 2001;7:211–28.
21. Vignon E, Bejui J, Mathieu P, Hartmann JD, Ville G, Evreux JC, et al. Histological
cartilage changes in a rabbit model of osteoarthritis. J Rheumatol. 1987;14:104–6.
22. Yoshioka M, Coutts RD, Amiel D, Hacker SA. Characterization of a model of
osteoarthritis in the rabbit knee. Osteoarthritis Cartilage. 1996;4:87–98.
23. Hayashi M, Muneta T, Takahashi T, Ju YJ, Tsuji K, Sekiya I. Intra-articular
injections of bone morphogenetic protein-7 retard progression of existing
cartilage degeneration. J Orthop Res. 2010;28:1502–6.
24. Inoue A, Takahashi KA, Arai Y, Tonomura H, Sakao K, Saito M, et al. The
therapeutic effects of basic fibroblast growth factor contained in gelatin
hydrogel microspheres on experimental osteoarthritis in the rabbit knee.
Arthritis Rheum. 2006;54:264–70.
25. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al.
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis
Cartilage. 2006;14:13–29.
26. Mitsui H, Aoyama T, Furu M, Ito K, Jin Y, Maruyama T, et al. Prostaglandin E2
receptor type 2-selective agonist prevents the degeneration of articular
cartilage in rabbit knees with traumatic instability. Arthritis Res Ther.
2011;13:R146.
27. Kawamoto T. Use of a new adhesive film for the preparation of multi-
purpose fresh-frozen sections from hard tissues, whole-animals, insects and
plants. Arch Histol Cytol. 2003;66:123–43.
28. Hashizume M, Koike N, Yoshida H, Suzuki M, Mihara M. High molecular
weight hyaluronic acid relieved joint pain and prevented the progression of
cartilage degeneration in a rabbit osteoarthritis model after onset of
arthritis. Mod Rheumatol. 2010;20:432–8.
29. François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, et al.
Activation of the peroxisome proliferator-activated receptor alpha pathway
potentiates interleukin-1 receptor antagonist production in cytokine-treated
chondrocytes. Arthritis Rheum. 2006;54:1233–45.
30. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al.
Immunomodulatory effect of human adipose tissue-derived adult stem
cells: comparison with bone marrow mesenchymal stem cells. Br J
Haematol. 2005;129:118–29.
31. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human
adipose tissue is a source of multipotent stem cells. Mol Biol Cell.
2002;13:4279–95.
32. Hatsushika D, Muneta T, Horie M, Koga H, Tsuji K, Sekiya I. Intraarticular
injection of synovial stem cells promotes meniscal regeneration in a rabbit
massive meniscal defect model. J Orthop Res. 2013;31:1354–9.
33. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem
cells derived from various mesenchymal tissues: superiority of synovium as
a cell source. Arthritis Rheum. 2005;52:2521–9.
34. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, et al.
Multipotential differentiation of adipose tissue-derived stem cells. Keio J
Med. 2005;54:132–41.
35. Fraser JK, Zhu M, Wulur I, Alfonso Z. Adipose-derived stem cells. Methods
Mol Biol. 2008;449:59–67.
36. O'Sullivan J, D'Arcy S, Barry FP, Murphy JM, Coleman CM. Mesenchymal
chondroprogenitor cell origin and therapeutic potential. Stem Cell Res Ther.
2011;18:8.
37. Lee KB, Hui JH, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem
cell therapy for large cartilage defects–a porcine model. Stem Cells.
2007;25:2964–71.
38. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell
Biochem. 2006;98:1076–84.
39. Nöth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem
cells for osteoarthritis therapy. Nat Clin Pract Rheumatol. 2008;4:371–80.
40. Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells–
basic and clinical implications for novel cell-based therapies. Stem Cells.
2007;25:818–27.
41. Nathan S, De Das S, Thambyah A, Fen C, Goh J, Lee EH. Cell-based therapy
in the repair of osteochondral defects: a novel use for adipose tissue. Tissue
Eng. 2003;9:733–44.
42. Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, Park SH, et al. Mesenchymal stem
cell injections improve symptoms of knee osteoarthritis. Arthroscopy.
2013;29:748–55.
Kuroda et al. BMC Musculoskeletal Disorders  (2015) 16:236 Page 9 of 10
43. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of
adipose-derived stromal vascular fraction or bone marrow-derived
mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res.
2009;27:1675–80.
44. Wu L, Cai X, Zhang S, Karperien M, Lin Y. Regeneration of articular cartilage
by adipose tissue derived mesenchymal stem cells: perspectives from stem
cell biology and molecular medicine. J Cell Physiol. 2013;228:938–44.
45. Tsuchiya K, Chen G, Ushida T, Matsuno T, Tateishi T. The effect of coculture
of chondrocytes with mesenchymal stem cells on their cartilaginous
phenotype in vitro. Mater Sci Eng. 2004;24:6.
46. Hildner F, Concaro S, Peterbauer A, Wolbank S, Danzer M, Lindahl A, et al.
Human adipose-derived stem cells contribute to chondrogenesis in
coculture with human articular chondrocytes. Tissue Eng Part A.
2009;15:3961–9.
47. Shirai T, Kobayashi M, Nishitani K, Satake T, Kuroki H, Nakagawa Y, et al.
Chondroprotective effect of alendronate in a rabbit model of osteoarthritis.
J Orthop Res. 2011;29:1572–7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kuroda et al. BMC Musculoskeletal Disorders  (2015) 16:236 Page 10 of 10
